Study on the possibility of insulin as a carrier of IUdR for hepatocellular carcinoma-targeted therapy

Figure 1 Insulin and insulin-IUdR analysis by HPLC. Reten-tion time of insulin was 8.81 minutes (A); Retention time of insulin-IUdR was 13.91 minutes (B).

Figure 2 Saturation binding curves of ¹²⁵I-insulin in hepatocel-lular carcinoma and its adjacent tissue.

Figure 3 The Scatchard plot corresponding to the saturation binding.

Figure 4 Competitive binding curves of ¹²⁵I-insulin against insulin-IUdR or insulin.